Tutorials
Curis Inc logo

Curis Inc

$ 1.00 +0.0111 (+1.12%) 10:08 PM EST
P/E:
At Loss
P/B:
1.21
Market Cap:
$ 91.81M
Enterprise V:
$ -25.07M
Volume:
3.59M
Avg Vol (2M):
3.24M
Also Trade In:
Volume:
3.59M
Market Cap $:
91.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.24M
Enterprise Value $:
-25.07M
PB Ratio:
1.21
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Curis Inc
NAICS : 325414 SIC : 2836
128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Name Current Vs Industry Vs History
Cash-To-Debt 32.05
Equity-to-Asset 0.54
Debt-to-Equity 0.05
Debt-to-EBITDA -0.08
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.22
Distress
Grey
Safe
Beneish M-Score -3.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.93
9-Day RSI 41.14
14-Day RSI 44.53
6-1 Month Momentum % -66.45
12-1 Month Momentum % -85.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.02
Quick Ratio 13.02
Cash Ratio 12.45
Days Sales Outstanding 88.88
Days Payable 3128.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.3

Financials (Next Earnings Date:2022-11-09 Est.)

CRIS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CRIS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.517
EPS (TTM) ($) -0.57
Beta 2.81
Volatility % 83.61
14-Day RSI 44.53
14-Day ATR ($) 0.100089
20-Day SMA ($) 1.10573
12-1 Month Momentum % -85.66
52-Week Range ($) 0.7 - 9.04
Shares Outstanding (Mil) 91.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Curis Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More